Lightfoot; Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lightfoot; Andrew.The latest application filed is for "method for the treatment of a relapsing-remitting condition".

Company Profile

1.9.14

Lightfoot; Andrew - Cambridgeshire GB
Lightfoot; Andrew - Stevenage GB
Lightfoot; Andrew - Ware GB
Lightfoot; Andrew - Middlesex N/A GB
Lightfoot; Andrew - Harlow GB
Lightfoot; Andrew - Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For The Treatment Of A Relapsing-remitting Condition App 20220281929 - Lightfoot; Andrew ; et al.	2022-09-08
Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof Grant 11,098,090 - Lightfoot , et al. August 24, 2	2021-08-24
Method for the Treatment of a Relapsing-Remitting Condition App 20210230233 - Lightfoot; Andrew ; et al.	2021-07-29
Mycobacteria Tuberculosis Chaperonin 60.1 Peptides and Uses Thereof App 20200071365 - Lightfoot; Andrew ; et al.	2020-03-05
Peptides from chaperonin 60.1 Grant 9,320,791 - Coates , et al. April 26, 2	2016-04-26
Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer'S disease Grant 9,133,178 - Dean , et al. September 15, 2	2015-09-15
Indole and azaindole modulators of the alpha 7 nAChR App 20150005321 - Dinnell; Kevin ; et al.	2015-01-01
Novel pepetides App 20140341932 - Coates; Anthony Robert Milnes ; et al.	2014-11-20
Indole and azaindole modulators of the alpha 7 nachr Grant 8,796,283 - Dinnell , et al. August 5, 2	2014-08-05
Alpha-7 Nicotinic Receptor Modulators For The Treatment Of Pain, A Psychotic Disorder, Cognitive Impairment Or Alzheimer's Disease App 20130310380 - Dean; David ; et al.	2013-11-21
Indole And Azaindole Modulators Of The Alpha 7 Nachr App 20120283273 - Dinnell; Kevin ; et al.	2012-11-08
2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use Grant 7,504,392 - Forbes , et al. March 17, 2	2009-03-17
Aromatic Sulfones And Their Medical Use App 20080269197 - Forbes; Ian Thomson ; et al.	2008-10-30
Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) Grant 7,429,579 - Hadley , et al. September 30, 2	2008-09-30
Dopamine receptor modulators as antipsychotic agents App 20070043026 - Cooper; David Gwyn ; et al.	2007-02-22
Aminopiperidine derivatives as antibacterials App 20060079546 - Davies; David Thomas ; et al.	2006-04-13
Aminopiperidine derivatives as antibacterials Grant 7,001,913 - Davies , et al. February 21, 2	2006-02-21
Compounds App 20050261279 - Forbes, Ian Thomson ; et al.	2005-11-24
7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents App 20050245507 - Forbes, Ian Thomson ; et al.	2005-11-03
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) App 20040171606 - Hadley, Michael Stewart ; et al.	2004-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.